{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:24:15Z","timestamp":1768724655941,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cbi.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T13:45:12Z","timestamp":1494942312000},"page":"92-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: Immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2"],"prefix":"10.1016","volume":"272","author":[{"given":"Sarah M.","family":"Mosaad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan A.","family":"Zaitone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelazim","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani A.","family":"El-Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina M.","family":"Abo-Elmatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser M.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.05.012_bib1","first-page":"102","article-title":"Review of the cardiovascular safety of COXIBs compared to NSAIDS","volume":"19","author":"Moodley","year":"2008","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.cbi.2017.05.012_bib2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2017.05.012_bib3","first-page":"6045","article-title":"Celecoxib prevents tumor growth in\u00a0vivo without toxicity to normal gut: lack of correlation between in\u00a0vitro and in\u00a0vivo models","volume":"60","author":"Williams","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib4","first-page":"6706","article-title":"Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors","volume":"62","author":"Zweifel","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib5","first-page":"5778","article-title":"Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11","volume":"62","author":"Trifan","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrd1225","article-title":"COX-2 and beyond: approaches to prostaglandin inhibition in human disease","volume":"2","author":"FitzGerald","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2017.05.012_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/FJC.0b013e31821c8353","article-title":"Effect of evening primrose oil and \u03c9-3 polyunsaturated fatty acids on the cardiovascular risk of celecoxib in rats","volume":"58","author":"Zaitone","year":"2011","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib8","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38195-9","article-title":"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids","volume":"289","author":"Catella-Lawson","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2017.05.012_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.0000153150.27690.f2","article-title":"Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins","volume":"96","author":"Rabausch","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1023226616526","article-title":"The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase","volume":"27","author":"Saini","year":"2003","journal-title":"Inflammation"},{"key":"10.1016\/j.cbi.2017.05.012_bib12","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20070828","article-title":"COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation","volume":"204","author":"Ghosh","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib13","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/01.CCM.0000069339.42383.16","article-title":"Endothelial cells play an important role in the antiaggregatory effect of nitric oxide","volume":"31","author":"Klinge","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1172\/JCI115906","article-title":"Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase","volume":"90","author":"Arnal","year":"1992","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI115849","article-title":"Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage","volume":"90","author":"Baylis","year":"1992","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.lfs.2003.07.032","article-title":"Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension","volume":"74","author":"Simko","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2017.05.012_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00024382-200203000-00005","article-title":"L-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats","volume":"17","author":"Liu","year":"2002","journal-title":"Shock Augusta Ga"},{"key":"10.1016\/j.cbi.2017.05.012_bib18","doi-asserted-by":"crossref","first-page":"C1140","DOI":"10.1152\/ajpcell.00462.2002","article-title":"Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis","volume":"284","author":"Weller","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1053-2498(01)00404-1","article-title":"Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: implications for treatment of end-stage heart failure","volume":"21","author":"Mital","year":"2002","journal-title":"J.\u00a0Heart Lung Transpl. Off. Publ. Int. Soc. Heart Transpl."},{"key":"10.1016\/j.cbi.2017.05.012_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1440-1681.2011.05628.x","article-title":"Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase","volume":"39","author":"Lv","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0959-437X(94)90076-F","article-title":"Programmed cell death in Caenorhabditis elegans","volume":"4","author":"Hengartner","year":"1994","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.cbi.2017.05.012_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.yjmcc.2003.10.001","article-title":"Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models","volume":"35","author":"Liang","year":"2003","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by Celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2017.05.012_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.20.3.298","article-title":"Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension","volume":"20","author":"Ribeiro","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.HYP.21.6.944","article-title":"Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade","volume":"21","author":"Jover","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.HYP.23.6.865","article-title":"Role of kinins and nitric oxide in the antihypertrophic effect of ramipril","volume":"23","author":"Rhaleb","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib27","first-page":"623","article-title":"Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia","volume":"12","author":"Bab\u00e1l","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.cbi.2017.05.012_bib28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.HYP.30.5.1097","article-title":"Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats","volume":"30","author":"Chillon","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.STR.29.5.1031","article-title":"Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery","volume":"29","author":"Moreau","year":"1998","journal-title":"Stroke J. Cereb. Circ."},{"key":"10.1016\/j.cbi.2017.05.012_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.26.6.957","article-title":"Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats","volume":"26","author":"Numaguchi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00788911","article-title":"Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease","volume":"91","author":"Moreno","year":"1996","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet lond. Engl."},{"key":"10.1016\/j.cbi.2017.05.012_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.80.1.1","article-title":"Endothelium-derived relaxing factor and coronary vasospasm","volume":"80","author":"Vanhoutte","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2017.05.012_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.2008.507","article-title":"Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats","volume":"75","author":"Ikeda","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2017.05.012_bib35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/01480540903575691","article-title":"Pathological and biochemical effects of therapeutic and supratherapeutic doses of celecoxib in Wistar albino male rats","volume":"33","author":"Ko\u00e7kaya","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.cbi.2017.05.012_bib36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib37","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00369.2007","article-title":"A\u00a0role for the thromboxane receptor in L-NAME hypertension","volume":"295","author":"Francois","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.fjc.0000210071.54828.9b","article-title":"Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats","volume":"47","author":"Zanfolin","year":"2006","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2017.05.012_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2012.06.022","article-title":"Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF","volume":"691","author":"Zaitone","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1139\/cjpp-2014-0524","article-title":"Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma","volume":"93","author":"Ali","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib42","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"Ruifrok","year":"2001","journal-title":"Anal. Quant. Cytol. Histol. Int. Acad. Cytol. Am. Soc. Cytol."},{"key":"10.1016\/j.cbi.2017.05.012_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/728741","article-title":"An altered pattern of myocardial histopathological and molecular changes underlies the different characteristics of Type-1 and Type-2 diabetic cardiac dysfunction","volume":"2015","author":"Radovits","year":"2015","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib44","first-page":"357","article-title":"Left ventricular hypertrophy is prevalent in Sprague-Dawley rats","volume":"60","author":"McAdams","year":"2010","journal-title":"Comp. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yjmcc.2010.04.002","article-title":"Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2","volume":"49","author":"Papanicolaou","year":"2010","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-364932-4.50010-1","article-title":"Apoptosis: mechanisms and roles in pathology","volume":"32","author":"Arends","year":"1991","journal-title":"Int. Rev. Exp. Pathol."},{"key":"10.1016\/j.cbi.2017.05.012_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/002215540205000401","article-title":"Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3","volume":"50","author":"Gown","year":"2002","journal-title":"J.\u00a0Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"10.1016\/j.cbi.2017.05.012_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00428-005-0073-5","article-title":"Immunohistochemical expression of activated caspase-3 in human myocardial infarction","volume":"448","author":"Zidar","year":"2006","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.cbi.2017.05.012_bib49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2017.05.012_bib50","first-page":"H52","article-title":"Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in\u00a0vivo","volume":"274","author":"Devlin","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005344-200202000-00006","article-title":"Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis","volume":"39","author":"Pacca","year":"2002","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(95)00625-X","article-title":"Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis","volume":"287","author":"Moreno","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.etap.2014.07.011","article-title":"Vanillic acid: a potential inhibitor of cardiac and aortic wall remodeling in l-NAME induced hypertension through upregulation of endothelial nitric oxide synthase","volume":"38","author":"Kumar","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib54","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/00004872-200018120-00013","article-title":"Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II","volume":"18","author":"Kitamoto","year":"2000","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.cbi.2017.05.012_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/bbrc.1993.1622","article-title":"L-arginine inhibits balloon catheter-induced intimal hyperplasia","volume":"193","author":"McNamara","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2017.05.012_bib56","first-page":"353","article-title":"L-NAME-induced protein remodeling and fibrosis in the rat heart","volume":"48","author":"Pech\u00e1nov\u00e1","year":"1999","journal-title":"Physiol. Res. Acad. Sci. Bohemoslov."},{"key":"10.1016\/j.cbi.2017.05.012_bib57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004872-200305000-00025","article-title":"Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy","volume":"21","author":"Rossi","year":"2003","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.cbi.2017.05.012_bib58","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1172\/JCI118280","article-title":"Stretch-induced programmed myocyte cell death","volume":"96","author":"Cheng","year":"1995","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib59","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI316","article-title":"Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell","volume":"101","author":"Leri","year":"1998","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib60","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.lfs.2004.11.028","article-title":"Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction","volume":"76","author":"Smith","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2017.05.012_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jjcc.2008.07.018","article-title":"Valsartan improves l-NAME-exacerbated cardiac fibrosis with TGF-\u03b2 inhibition and apoptosis induction in spontaneously hypertensive rats","volume":"52","author":"Akashiba","year":"2008","journal-title":"J.\u00a0Cardiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.34.4.609","article-title":"Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR","volume":"34","author":"Ono","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib63","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2006-02-005330","article-title":"Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors","volume":"108","author":"Anning","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2017.05.012_bib64","first-page":"28","article-title":"Nuclear factor-kappaB activation: a question of life or death","volume":"35","author":"Shishodia","year":"2002","journal-title":"J.\u00a0Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2017.05.012_bib65","doi-asserted-by":"crossref","first-page":"132ra54","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0955-0674(95)80030-1","article-title":"Molecular control of life and death","volume":"7","author":"Yuan","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cbi.2017.05.012_bib67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gastro.2005.06.003","article-title":"Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via Cyclooxygenase-2","volume":"129","author":"Komatsu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2017.05.012_bib68","doi-asserted-by":"crossref","first-page":"48997","DOI":"10.1074\/jbc.M107829200","article-title":"Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells: INVOLVEMENT of phosphatidylinositol 3-kinase\/akt pathway","volume":"276","author":"Lin","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2017.05.012_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2009.07.021","article-title":"Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis","volume":"79","author":"Rudner","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib70","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jtcvs.2010.06.057","article-title":"Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium","volume":"140","author":"Robich","year":"2010","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.cbi.2017.05.012_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jcmm.12709","article-title":"Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress","volume":"20","author":"Zhang","year":"2016","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib72","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1172\/JCI118747","article-title":"Apoptosis in pressure overload-induced heart hypertrophy in the rat","volume":"97","author":"Teiger","year":"1996","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.05.012_bib73","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","article-title":"Apoptosis in the failing human heart","volume":"336","author":"Olivetti","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2017.05.012_bib74","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.CIR.99.23.3071","article-title":"Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat","volume":"99","author":"Condorelli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2017.05.012_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bcp.2004.03.029","article-title":"Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells","volume":"68","author":"Niederberger","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2017.05.012_bib76","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by Celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett."},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2017.05.012_bib77","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/S0753-3322(05)80045-9","article-title":"Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells","volume":"59","author":"Lev-Ari","year":"2005","journal-title":"Biomed. Pharmacother. Biom\u00e9d. Pharmacoth\u00e9rapie"},{"key":"10.1016\/j.cbi.2017.05.012_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2004.11.002","article-title":"Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in\u00a0vitro","volume":"224","author":"Subhashini","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2017.05.012_bib79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/cvr\/28.8.1199","article-title":"Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure","volume":"28","author":"Olivetti","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2017.05.012_bib80","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1006\/jmcc.1997.0465","article-title":"Localization of alpha1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure","volume":"29","author":"Bing","year":"1997","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2017.05.012_bib81","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/hy1201.099615","article-title":"Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management","volume":"38","author":"Fortu\u00f1o","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2017.05.012_bib82","first-page":"831","article-title":"Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?","volume":"3","author":"Howes","year":"2007","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717303940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717303940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:45:01Z","timestamp":1757857501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717303940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":82,"alternative-id":["S0009279717303940"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.05.012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: Immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}